Vaccine-maker Moderna (MRNA) reports 4Q earnings before markets open Thursday, Feb. 24, 2022. Brad Loncar breaks down expectations for the quarterly report, as well as how the company has performed over the past few years since the start of the COVID-19 pandemic. Consensus calls for Moderna to report EPS of $9.82 on $6.71B in total revenue. The stock is down nearly 50 percent year-to-date and has underperformed the broader market.
23 Feb 2022
Trading 360
23 Feb 2022
Morning Trade Live
18 Mar 2022
Trading 360
28 Apr 2022
Market On Close
05 May 2022
The Watch List
01 Apr 2022
Trading 360
29 Apr 2022